Lynx1 Capital Management LP - Dec 2, 2025 SCHEDULE 13D/A Report for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share
Symbol: NEUP
Shares outstanding: 5.37M shares
Disclosed Ownership: 875K shares
Ownership: 16.3%
Form type: SCHEDULE 13D/A
Date filed: 12/2/2025, 08:20 AM
Date of event: Dec 2, 2025
Previous filing: Nov 28, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	16.3%	875K	0	875K	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member	0001910456
Weston Nichols	16.3%	875K	0	875K	/s/ Weston Nichols	Weston Nichols, individually